The global in-vitro toxicology testing market size was USD 10.99 billion in 2023, calculated at USD 11.92 billion in 2024 and is projected to surpass around USD 30.06 billion by 2033, expanding at a CAGR of 10.82% from 2024 to 2033.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on In-Vitro Toxicology Testing Market
5.1. COVID-19 Landscape: In-Vitro Toxicology Testing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global In-Vitro Toxicology Testing Market, By Technology
8.1. In-Vitro Toxicology Testing Market, by Technology, 2024-2033
8.1.1. Cell Culture Technology
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. High Throughput Technology
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Molecular Imaging
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. OMICS Technology
8.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global In-Vitro Toxicology Testing Market, By Application
9.1. In-Vitro Toxicology Testing Market, by Application, 2024-2033
9.1.1. Systemic Toxicology
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Dermal Toxicity
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Endocrine Disruption
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Occular Toxicity
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global In-Vitro Toxicology Testing Market, By Method
10.1. In-Vitro Toxicology Testing Market, by Method, 2024-2033
10.1.1. Cellular Assay
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Biochemical Assay
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. In-silico
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Ex-vivo
10.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global In-Vitro Toxicology Testing Market, By End-user
11.1. In-Vitro Toxicology Testing Market, by End-user, 2024-2033
11.1.1. Pharmaceutical Industry
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Cosmetics & Household Products
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Academic Institutes & Research Laboratories
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Diagnostics
11.1.4.1. Market Revenue and Forecast (2021-2033)
11.1.5. Chemicals Industry
11.1.5.1. Market Revenue and Forecast (2021-2033)
11.1.6. Food Industry
11.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global In-Vitro Toxicology Testing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Technology (2021-2033)
12.1.2. Market Revenue and Forecast, by Application (2021-2033)
12.1.3. Market Revenue and Forecast, by Method (2021-2033)
12.1.4. Market Revenue and Forecast, by End-user (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Method (2021-2033)
12.1.5.4. Market Revenue and Forecast, by End-user (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Method (2021-2033)
12.1.6.4. Market Revenue and Forecast, by End-user (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.3. Market Revenue and Forecast, by Method (2021-2033)
12.2.4. Market Revenue and Forecast, by End-user (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Method (2021-2033)
12.2.5.4. Market Revenue and Forecast, by End-user (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Method (2021-2033)
12.2.6.4. Market Revenue and Forecast, by End-user (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Method (2021-2033)
12.2.7.4. Market Revenue and Forecast, by End-user (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Method (2021-2033)
12.2.8.4. Market Revenue and Forecast, by End-user (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.3. Market Revenue and Forecast, by Method (2021-2033)
12.3.4. Market Revenue and Forecast, by End-user (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Method (2021-2033)
12.3.5.4. Market Revenue and Forecast, by End-user (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Method (2021-2033)
12.3.6.4. Market Revenue and Forecast, by End-user (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Method (2021-2033)
12.3.7.4. Market Revenue and Forecast, by End-user (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Method (2021-2033)
12.3.8.4. Market Revenue and Forecast, by End-user (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.3. Market Revenue and Forecast, by Method (2021-2033)
12.4.4. Market Revenue and Forecast, by End-user (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Method (2021-2033)
12.4.5.4. Market Revenue and Forecast, by End-user (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Method (2021-2033)
12.4.6.4. Market Revenue and Forecast, by End-user (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Method (2021-2033)
12.4.7.4. Market Revenue and Forecast, by End-user (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Method (2021-2033)
12.4.8.4. Market Revenue and Forecast, by End-user (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.5.3. Market Revenue and Forecast, by Method (2021-2033)
12.5.4. Market Revenue and Forecast, by End-user (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Method (2021-2033)
12.5.5.4. Market Revenue and Forecast, by End-user (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Method (2021-2033)
12.5.6.4. Market Revenue and Forecast, by End-user (2021-2033)
Chapter 13. Company Profiles
13.1. Charles River Laboratories International, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. SGS S.A.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Merck KGaA
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Eurofins Scientific
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Abbott Laboratories
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Laboratory Corporation of America Holdings
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Evotec S.E.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Thermo Fisher Scientific, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Quest Diagnostics Incorporated
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Agilent Technolgies, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample